Identifying CYP2D6 intermediate and poor metabolizers among schizophrenic patients with respect to therapeutical response.

Juřica,  Jan; Bartečková,  Eliška; Zendulka,  Ondřej; Kašpárek,  Tomáš; Pindurová,  Eva; Šulcová,  Alexandra

Identifying CYP2D6 intermediate and poor metabolizers among schizophrenic patients with respect to therapeutical response.

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Authors	JUŘICA Jan BARTEČEK Richard ZENDULKA Ondřej KAŠPÁREK Tomáš FLODROVÁ Eva ŠULCOVÁ Alexandra
Year of publication	2010
Type	Conference abstract
MU Faculty or unit	Faculty of Medicine
Citation
Description	The study sumarizes the knowledge of the correlation of metabolic phenotype and genotype of CYP2D6 with the therapeutical response in first episode- schizphrenic patients treated with risperidone.
Related projects:	The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions. Vliv farmakogenetických a farmakokinetických faktorů na účinnost a bezpečnost terapie prvních epizod schizofrenie